Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 107

1.

Reply to Sabah et al.

Kettler B, Scheffner I, Bräsen JH, Hallensleben M, Richter N, Heiringhoff KH, Lehner F, Klempnauer J, Gwinner W.

Transpl Int. 2019 Dec;32(12):1341-1342. doi: 10.1111/tri.13522. No abstract available.

PMID:
31519055
2.

Kidney injury enhances renal G-CSF expression and modulates granulopoiesis and human neutrophil CD177 in vivo.

Volkmann J, Schmitz J, Nordlohne J, Dong L, Helmke A, Sen P, Immenschuh S, Bernhardt WM, Gwinner W, Bräsen JH, Schmitt R, Haller H, von Vietinghoff S.

Clin Exp Immunol. 2019 Sep 11. doi: 10.1111/cei.13372. [Epub ahead of print]

PMID:
31509227
3.

Patient survival after kidney transplantation: important role of graft-sustaining factors as determined by predictive modeling using random survival forest analysis.

Scheffner I, Gietzelt M, Abeling T, Marschollek M, Gwinner W.

Transplantation. 2019 Aug 8. doi: 10.1097/TP.0000000000002922. [Epub ahead of print]

PMID:
31403555
4.

Development and validation of a peripheral blood mRNA assay for the assessment of antibody-mediated kidney allograft rejection: A multicentre, prospective study.

Van Loon E, Gazut S, Yazdani S, Lerut E, de Loor H, Coemans M, Noël LH, Thorrez L, Van Lommel L, Schuit F, Sprangers B, Kuypers D, Essig M, Gwinner W, Anglicheau D, Marquet P, Naesens M.

EBioMedicine. 2019 Aug;46:463-472. doi: 10.1016/j.ebiom.2019.07.028. Epub 2019 Aug 1.

5.

Kidney graft survival of >25 years: a single center report including associated graft biopsy results.

Kettler B, Scheffner I, Bräsen JH, Hallensleben M, Richter N, Heiringhoff KH, Lehner F, Klempnauer J, Gwinner W.

Transpl Int. 2019 Dec;32(12):1277-1285. doi: 10.1111/tri.13469. Epub 2019 Jul 9.

PMID:
31188498
6.

Chemokine CXCL13 as a New Systemic Biomarker for B-Cell Involvement in Acute T Cell-Mediated Kidney Allograft Rejection.

Schiffer L, Wiehler F, Bräsen JH, Gwinner W, Greite R, Kreimann K, Thorenz A, Derlin K, Teng B, Rong S, von Vietinghoff S, Haller H, Mengel M, Pape L, Lerch C, Schiffer M, Gueler F.

Int J Mol Sci. 2019 May 24;20(10). pii: E2552. doi: 10.3390/ijms20102552.

7.

Molecular Patterns Discriminate Accommodation and Subclinical Antibody-mediated Rejection in Kidney Transplantation.

Hruba P, Krejcik Z, Stranecky V, Maluskova J, Slatinska J, Gueler F, Gwinner W, Bräsen JH, Wohlfahrtova M, Parikova A, Osickova K, Fronek J, Seda O, Prefertusova L, Honsova E, Viklicky O.

Transplantation. 2019 May;103(5):909-917. doi: 10.1097/TP.0000000000002604.

PMID:
30801516
8.

Proteomics in Kidney Allograft Transplantation-Application of Molecular Pathway Analysis for Kidney Allograft Disease Phenotypic Biomarker Selection.

Marx D, Metzger J, Olagne J, Belczacka I, Faguer S, Colombat M, Husi H, Mullen W, Gwinner W, Caillard S.

Proteomics Clin Appl. 2019 Mar;13(2):e1800091. doi: 10.1002/prca.201800091. Epub 2019 Feb 4. Review.

PMID:
30680934
9.

Natural killer cell infiltration is discriminative for antibody-mediated rejection and predicts outcome after kidney transplantation.

Yazdani S, Callemeyn J, Gazut S, Lerut E, de Loor H, Wevers M, Heylen L, Saison C, Koenig A, Thaunat O, Thorrez L, Kuypers D, Sprangers B, Noël LH, Van Lommel L, Schuit F, Essig M, Gwinner W, Anglicheau D, Marquet P, Naesens M.

Kidney Int. 2019 Jan;95(1):188-198. doi: 10.1016/j.kint.2018.08.027. Epub 2018 Nov 3.

10.

Risk factors for death in kidney transplant patients: analysis from a large protocol biopsy registry.

Abeling T, Scheffner I, Karch A, Broecker V, Koch A, Haller H, Schwarz A, Gwinner W.

Nephrol Dial Transplant. 2019 Jul 1;34(7):1171-1181. doi: 10.1093/ndt/gfy131.

PMID:
29860340
11.

Distinct morphological features of acute tubular injury in renal allografts correlate with clinical outcome.

Schumann-Bischoff A, Schmitz J, Scheffner I, Schmitt R, Broecker V, Haller H, Bräsen JH, Gwinner W.

Am J Physiol Renal Physiol. 2018 Sep 1;315(3):F701-F710. doi: 10.1152/ajprenal.00189.2017. Epub 2018 Apr 11.

12.

Assessment of acute kidney injury with T1 mapping MRI following solid organ transplantation.

Peperhove M, Vo Chieu VD, Jang MS, Gutberlet M, Hartung D, Tewes S, Warnecke G, Fegbeutel C, Haverich A, Gwinner W, Lehner F, Bräsen JH, Haller H, Wacker F, Gueler F, Hueper K.

Eur Radiol. 2018 Jan;28(1):44-50. doi: 10.1007/s00330-017-4943-4. Epub 2017 Jul 14.

PMID:
28710580
13.

Autophagy in kidney transplants of sirolimus treated recipients.

Bhayana S, Baisantry A, Kraemer TD, Wrede C, Hegermann J, Bräsen JH, Bockmeyer C, Ulrich Becker J, Ochs M, Gwinner W, Haller H, Melk A, Schmitt R.

J Nephropathol. 2017 Mar;6(2):90-96. doi: 10.15171/jnp.2017.15. Epub 2016 Oct 22.

14.

A case report of severe calciphylaxis - suggested approach for diagnosis and treatment.

Patecki M, Lehmann G, Bräsen JH, Schmitz J, Bertram A, Berthold LD, Haller H, Gwinner W.

BMC Nephrol. 2017 Apr 21;18(1):137. doi: 10.1186/s12882-017-0556-z.

15.

Establishing Biomarkers in Transplant Medicine: A Critical Review of Current Approaches.

Anglicheau D, Naesens M, Essig M, Gwinner W, Marquet P.

Transplantation. 2016 Oct;100(10):2024-38. doi: 10.1097/TP.0000000000001321. Review.

PMID:
27479159
16.

Independent Pre-Transplant Recipient Cancer Risk Factors after Kidney Transplantation and the Utility of G-Chart Analysis for Clinical Process Control.

Schrem H, Schneider V, Kurok M, Goldis A, Dreier M, Kaltenborn A, Gwinner W, Barthold M, Liebeneiner J, Winny M, Klempnauer J, Kleine M.

PLoS One. 2016 Jul 11;11(7):e0158732. doi: 10.1371/journal.pone.0158732. eCollection 2016.

17.

[Weakness of the extremities in a 73-year-old male patient].

Attaran-Bandarabadi M, Kalbasi Anaraki P, Gwinner W, Haller H.

Internist (Berl). 2016 Aug;57(8):815-8. doi: 10.1007/s00108-016-0060-8. German.

PMID:
27167632
18.

Proteomics for rejection diagnosis in renal transplant patients: Where are we now?

Gwinner W, Metzger J, Husi H, Marx D.

World J Transplant. 2016 Mar 24;6(1):28-41. doi: 10.5500/wjt.v6.i1.28. Review.

19.

[Allocation systems in transplantation medicine: Advantages and disadvantages].

Gottlieb J, Gwinner W, Strassburg CP.

Internist (Berl). 2016 Jan;57(1):15-24. doi: 10.1007/s00108-015-3805-x. German.

PMID:
26782280
20.

Diffusion-Weighted imaging and diffusion tensor imaging detect delayed graft function and correlate with allograft fibrosis in patients early after kidney transplantation.

Hueper K, Khalifa AA, Bräsen JH, Vo Chieu VD, Gutberlet M, Wintterle S, Lehner F, Richter N, Peperhove M, Tewes S, Weber K, Haller H, Wacker F, Gwinner W, Gueler F, Hartung D.

J Magn Reson Imaging. 2016 Jul;44(1):112-21. doi: 10.1002/jmri.25158. Epub 2016 Jan 18.

PMID:
26778459
21.

Non-invasive diagnosis of acute rejection in renal transplant patients using mass spectrometry of urine samples - a multicentre phase 3 diagnostic accuracy study.

Zapf A, Gwinner W, Karch A, Metzger J, Haller H, Koch A.

BMC Nephrol. 2015 Sep 15;16:153. doi: 10.1186/s12882-015-0146-x.

22.

Long-term impact of CMV infection on allografts and on patient survival in renal transplant patients with protocol biopsies.

Erdbrügger U, Scheffner I, Mengel M, Schwarz A, Haller H, Gwinner W.

Am J Physiol Renal Physiol. 2015 Dec 1;309(11):F925-32. doi: 10.1152/ajprenal.00317.2015. Epub 2015 Sep 9.

23.

Molecular diagnostics identifies risks for graft dysfunction despite borderline histologic changes.

Hrubá P, Brabcová I, Gueler F, Krejčík Z, Stránecký V, Svobodová E, Malušková J, Gwinner W, Honsová E, Lodererová A, Oberbauer R, Zachoval R, Viklický O.

Kidney Int. 2015 Oct;88(4):785-95. doi: 10.1038/ki.2015.211. Epub 2015 Jul 15.

PMID:
26176825
24.

Functional MRI detects perfusion impairment in renal allografts with delayed graft function.

Hueper K, Gueler F, Bräsen JH, Gutberlet M, Jang MS, Lehner F, Richter N, Hanke N, Peperhove M, Martirosian P, Tewes S, Vo Chieu VD, Großhennig A, Haller H, Wacker F, Gwinner W, Hartung D.

Am J Physiol Renal Physiol. 2015 Jun 15;308(12):F1444-51. doi: 10.1152/ajprenal.00064.2015. Epub 2015 Apr 29.

25.

Indicators of treatment responsiveness to rituximab and plasmapheresis in antibody-mediated rejection after kidney transplantation.

Immenschuh S, Zilian E, Dämmrich ME, Schwarz A, Gwinner W, Becker JU, Blume CA.

Transplantation. 2015 Jan;99(1):56-62. doi: 10.1097/TP.0000000000000244. Erratum in: Transplantation. 2016 Mar;100(3):e15.

PMID:
25121474
26.

Progressive multifocal cerebral infarction in a young kidney transplant recipient due to thrombotic microangiopathy.

Haghikia A, Heeren M, Bockmeyer C, Haubitz B, Gwinner W.

BMC Nephrol. 2014 Apr 7;15:59. doi: 10.1186/1471-2369-15-59.

27.

High impact of rejection therapy on the incidence of post-transplant diabetes mellitus after kidney transplantation.

Schweer T, Gwinner W, Scheffner I, Schwarz A, Haller H, Blume C.

Clin Transplant. 2014 Apr;28(4):512-9. doi: 10.1111/ctr.12329. Epub 2014 Mar 21.

PMID:
24649873
28.

Histopathological and clinical findings in renal transplants with Banff type II and III acute cellular rejection without tubulointerstitial infiltrates.

Bröcker V, Hirzallah M, Gwinner W, Bockmeyer CL, Wittig J, Zell S, Agustian PA, Schwarz A, Ganzenmüller T, Zilian E, Immenschuh S, Becker JU.

Virchows Arch. 2014 Feb;464(2):203-11. doi: 10.1007/s00428-013-1487-0. Epub 2013 Dec 28.

PMID:
24374461
29.

Proteinuria and sirolimus after renal transplantation: a retrospective analysis from a large German multicenter database.

Naik MG, Heller KM, Arns W, Budde K, Diekmann F, Eitner F, Fischereder M, Goßmann J, Heyne N, Morath C, Riester U, Gwinner W, Jürgensen JS; German Sirolimus Study Group.

Clin Transplant. 2014 Jan;28(1):67-79. doi: 10.1111/ctr.12280. Epub 2013 Dec 26.

PMID:
24372584
30.

Preemptive treatment of Cytomegalovirus infection in kidney transplant recipients with letermovir: results of a Phase 2a study.

Stoelben S, Arns W, Renders L, Hummel J, Mühlfeld A, Stangl M, Fischereder M, Gwinner W, Suwelack B, Witzke O, Dürr M, Beelen DW, Michel D, Lischka P, Zimmermann H, Rübsamen-Schaeff H, Budde K.

Transpl Int. 2014 Jan;27(1):77-86. doi: 10.1111/tri.12225. Erratum in: Transpl Int. 2014 Apr;27(4):416.

31.

Beyond C4d: the ultrastructural appearances of endothelium in ABO-incompatible renal allografts.

Bröcker V, Pfaffenbach A, Habicht A, Chatzikyrkou C, Kreipe HH, Haller H, Scheffner I, Gwinner W, Zilian E, Immenschuh S, Schwarz A, Horn PA, Heinemann FM, Becker JU.

Nephrol Dial Transplant. 2013 Dec;28(12):3101-9. doi: 10.1093/ndt/gft373. Epub 2013 Sep 29.

PMID:
24081856
32.

High-urgency renal transplantation: indications and long-term outcomes.

Kousoulas L, Emmanouilidis N, Gwinner W, Klempnauer J, Lehner F.

J Transplant. 2013;2013:314239. doi: 10.1155/2013/314239. Epub 2013 Feb 7.

33.

Urinary NGAL Ratio Is Not a Sensitive Biomarker for Monitoring Acute Tubular Injury in Kidney Transplant Patients: NGAL and ATI in Renal Transplant Patients.

Kaufeld JK, Gwinner W, Scheffner I, Haller HG, Schiffer M.

J Transplant. 2012;2012:563404. doi: 10.1155/2012/563404. Epub 2012 Dec 27.

34.

Fetuin, matrix-Gla protein and osteopontin in calcification of renal allografts.

Lorenzen JM, Martino F, Scheffner I, Bröcker V, Leitolf H, Haller H, Gwinner W.

PLoS One. 2012;7(12):e52039. doi: 10.1371/journal.pone.0052039. Epub 2012 Dec 17.

35.

Rationale and design of the RIACT-study: a multi-center placebo controlled double blind study to test the efficacy of RItuximab in Acute Cellular tubulointerstitial rejection with B-cell infiltrates in renal Transplant patients: study protocol for a randomized controlled trial.

Schiffer L, Schiffer M, Merkel S, Schwarz A, Mengel M, Jürgens C, Schroeder C, Zoerner AA, Püllmann K, Bröcker V, Becker JU, Dämmrich ME, Träder J, Grosshennig A, Biertz F, Haller H, Koch A, Gwinner W.

Trials. 2012 Oct 26;13:199. doi: 10.1186/1745-6215-13-199.

36.

PRKC-isoform mRNA expression in human kidney transplant protocol biopsies: is there a high-glucose-induced regulation in the diabetic state?

Kirsch T, Krech S, Krech T, Becker JU, Beese M, Gwinner W, Haller H, Meier M.

Acta Diabetol. 2013 Aug;50(4):655-6. doi: 10.1007/s00592-012-0408-z. Epub 2012 Jun 16. No abstract available.

PMID:
22706690
37.

Arteriolar lesions in renal transplant biopsies: prevalence, progression, and clinical significance.

Bröcker V, Schubert V, Scheffner I, Schwarz A, Hiss M, Becker JU, Scherer R, Haller H, Kreipe HH, Mengel M, Gwinner W.

Am J Pathol. 2012 May;180(5):1852-62. doi: 10.1016/j.ajpath.2012.01.038. Epub 2012 Mar 27.

PMID:
22464889
38.

Organ transplants do not escape paradoxical embolisms.

Haghikia A, Hiss M, Ringe KI, Schoenenberger E, Fischer D, Haller H, Gwinner W.

Transpl Int. 2012 Mar;25(3):e34-7. doi: 10.1111/j.1432-2277.2011.01415.x. Epub 2011 Dec 27.

39.

[Conversion from a calcineurin inhibitor to a sirolimus-based therapy after renal transplantation - An update of existing recommendations].

Arns W, Budde K, Eitner F, Gwinner W, Hugo C, Pressmar K, Weimann A, Witzke O.

Dtsch Med Wochenschr. 2011 Dec;136(49):2554-9. doi: 10.1055/s-0031-1292822. Epub 2011 Nov 30. German. No abstract available.

PMID:
22131077
40.

Pathogenesis and management of hypertension after kidney transplantation.

Chatzikyrkou C, Menne J, Gwinner W, Schmidt BM, Lehner F, Blume C, Schwarz A, Haller H, Schiffer M.

J Hypertens. 2011 Dec;29(12):2283-94. doi: 10.1097/HJH.0b013e32834bd1e7. Review.

PMID:
21970935
41.

Urinary miR-210 as a mediator of acute T-cell mediated rejection in renal allograft recipients.

Lorenzen JM, Volkmann I, Fiedler J, Schmidt M, Scheffner I, Haller H, Gwinner W, Thum T.

Am J Transplant. 2011 Oct;11(10):2221-7. doi: 10.1111/j.1600-6143.2011.03679.x. Epub 2011 Aug 3.

42.

Impact of CMV infection on acute rejection and long-term renal allograft function: a systematic analysis in patients with protocol biopsies and indicated biopsies.

Erdbruegger U, Scheffner I, Mengel M, Schwarz A, Verhagen W, Haller H, Gwinner W.

Nephrol Dial Transplant. 2012 Jan;27(1):435-43. doi: 10.1093/ndt/gfr306. Epub 2011 Jun 28.

PMID:
21712490
43.

Diffusion tensor imaging and tractography for assessment of renal allograft dysfunction-initial results.

Hueper K, Gutberlet M, Rodt T, Gwinner W, Lehner F, Wacker F, Galanski M, Hartung D.

Eur Radiol. 2011 Nov;21(11):2427-33. doi: 10.1007/s00330-011-2189-0. Epub 2011 Jun 28.

PMID:
21710264
44.

Early posttransplantation hemoglobin level corresponds with chronic renal dysfunction in heart transplant recipients.

Zhang R, Georgiou M, Gwinner W, Zardo P, Haverich A, Bara C.

Transplant Proc. 2011 Jun;43(5):1939-43. doi: 10.1016/j.transproceed.2011.03.055.

PMID:
21693304
45.

Diagnosis of subclinical and clinical acute T-cell-mediated rejection in renal transplant patients by urinary proteome analysis.

Metzger J, Chatzikyrkou C, Broecker V, Schiffer E, Jaensch L, Iphoefer A, Mengel M, Mullen W, Mischak H, Haller H, Gwinner W.

Proteomics Clin Appl. 2011 Jun;5(5-6):322-33. doi: 10.1002/prca.201000153. Epub 2011 Apr 29.

PMID:
21538920
46.

Diminished met signaling in podocytes contributes to the development of podocytopenia in transplant glomerulopathy.

Agustian PA, Schiffer M, Gwinner W, Schäfer I, Theophile K, Modde F, Bockmeyer CL, Traeder J, Lehmann U, Grosshennig A, Kreipe HH, Bröcker V, Becker JU.

Am J Pathol. 2011 May;178(5):2007-19. doi: 10.1016/j.ajpath.2011.01.042.

47.

The molecular phenotype of 6-week protocol biopsies from human renal allografts: reflections of prior injury but not future course.

Mengel M, Chang J, Kayser D, Gwinner W, Schwarz A, Einecke G, Broecker V, Famulski K, de Freitas DG, Guembes-Hidalgo L, Sis B, Haller H, Halloran PF.

Am J Transplant. 2011 Apr;11(4):708-18. doi: 10.1111/j.1600-6143.2010.03339.x. Epub 2010 Nov 29.

48.

Association of high anti-donor alloreactivity and low frequency of FoxP3-expressing cells prior to kidney transplantation with acute graft rejection.

Vondran FW, Timrott K, Tross J, Kollrich S, Gwinner W, Lehner F, Klempnauer J, Becker T, Schwinzer R.

Clin Transplant. 2011 Nov-Dec;25(6):905-14. doi: 10.1111/j.1399-0012.2010.01354.x. Epub 2010 Nov 11.

PMID:
21070367
49.

Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease.

Good DM, Zürbig P, Argilés A, Bauer HW, Behrens G, Coon JJ, Dakna M, Decramer S, Delles C, Dominiczak AF, Ehrich JH, Eitner F, Fliser D, Frommberger M, Ganser A, Girolami MA, Golovko I, Gwinner W, Haubitz M, Herget-Rosenthal S, Jankowski J, Jahn H, Jerums G, Julian BA, Kellmann M, Kliem V, Kolch W, Krolewski AS, Luppi M, Massy Z, Melter M, Neusüss C, Novak J, Peter K, Rossing K, Rupprecht H, Schanstra JP, Schiffer E, Stolzenburg JU, Tarnow L, Theodorescu D, Thongboonkerd V, Vanholder R, Weissinger EM, Mischak H, Schmitt-Kopplin P.

Mol Cell Proteomics. 2010 Nov;9(11):2424-37. doi: 10.1074/mcp.M110.001917. Epub 2010 Jul 8.

50.

Necrotizing fasciitis and acute kidney injury in a patient with acute myelogenous leukemia-case presentation and review of the literature.

Lorenzen JM, Krauter J, Länger F, Haller H, Gwinner W.

Ann Hematol. 2011 Feb;90(2):235-8. doi: 10.1007/s00277-010-0995-0. Epub 2010 May 25. No abstract available.

PMID:
20499234

Supplemental Content

Loading ...
Support Center